BPC-157
5 mg
$29.00
Emideltide, catalogued as delta sleep-inducing peptide (DSIP), is a nonapeptide supplied as a lyophilized powder vial with a separate vial of bacteriostatic water for reconstitution.
For research and clinical use only. Supplied to licensed practitioners and research professionals. Not evaluated by the FDA.
Emideltide, catalogued as delta sleep-inducing peptide (DSIP), is a nonapeptide supplied as a lyophilized powder vial with a separate vial of bacteriostatic water for reconstitution.
Supplied to licensed practitioners and research professionals only. Sensitive to oxidation — keep sealed and minimize headspace exposure once opened. Store lyophilized at −20 °C. Not evaluated by the FDA and not intended to diagnose, treat, cure or prevent any disease.
| Available sizes | 5 mg — $35.00 · 10 mg — $55.00 |
| Form | Lyophilized powder + BAC water vial |
| Molecular weight | 848.8 g/mol |
| CAS | 62568-57-4 |
| Sequence length | 9 |
| Storage — sealed | −20 °C, protected from light |
| Storage — reconstituted | 2–8 °C, use within 14 days |
| Ships from | Chicago, IL |
| SKU | PEP-DSIP |
Research summary — for laboratory and research use only. Not medical advice, not a dosing recommendation, and not an FDA evaluation of safety or efficacy.
Delta sleep-inducing peptide (DSIP) was first isolated from rabbit cerebral venous blood in 1977 by Swiss researcher Karl Schoenenberger's group, making it one of the older characterized neuropeptides in this catalog. "Emideltide" is the compound's assigned INN-style name; DSIP remains its more common research designation.
Despite its name, DSIP's exact receptor and mechanism of action have never been fully resolved — no dedicated receptor has been definitively identified, and its effect on EEG delta-wave sleep in the original animal studies has been inconsistently replicated. Later research has looked more broadly at its role in stress-hormone regulation (ACTH, cortisol) than at sleep specifically.
The original and still most-cited research application is EEG-based sleep-stage studies in animal models, examining delta-wave (slow-wave) sleep.
A separate and arguably better-supported research thread looks at DSIP's interaction with the hypothalamic-pituitary-adrenal axis and circulating stress hormones.
Supplied to licensed practitioners and research professionals only. Sensitive to oxidation — keep sealed and minimize headspace exposure once opened. Store lyophilized at −20 °C. Not evaluated by the FDA and not intended to diagnose, treat, cure or prevent any disease.
No dedicated receptor has been conclusively identified in the literature. It's an active, somewhat unresolved area of peptide research rather than a mechanistically settled compound.
Further reading: for the published preclinical and clinical literature on Emideltide (DSIP), search PubMed. We link to the search rather than cherry-picked citations so you can review the current, full body of literature yourself.